India has a target of US$ 300 billion in bioeconomy by 2030 as the number of biotech firms in the nation is rising, according to Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh.

India's bioeconomy is expected to touch US$ 150 billion by 2025 and over US$ 300 billion by 2030, according to a report by the Biotechnology Industry Research Assistance Council (BIRAC).

The Indian biotech sector is projected to increase to US$ 150 billion in the next four years from the current size of US$ 70 billion, as per Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space Dr. Jitendra Singh.

India's 'bio economy' has grown from US$ 10 billion to US$ 80 billion in the last eight years, said Prime Minister Mr. Narendra Modi while addressing the Biotech Startup Expo in Delhi.

Bharat Biotech’s experimental nasal vaccine could prove to be a real game changer as it would lead to faster immunizations of entire populations, be more palatable to many than painful shots and would circumvent shortages of needles, syringes and other materials.